TreeWAS – Variant ID: rs2001846

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
E78.0 Pure hypercholesterolaemia	0.000	0.000	1.000
I25.1 Atherosclerotic heart disease	0.000	0.000	1.000
E78 Disorders of lipoprotein metabolism and other lipidaemias	0.000	0.003	0.997
E78.5 Hyperlipidaemia, unspecified	0.000	0.006	0.994
I25 Chronic ischaemic heart disease	0.000	0.074	0.926
E78.4 Other hyperlipidaemia	0.000	0.125	0.875
I25.3 Aneurysm of heart	0.000	0.151	0.849
E78.2 Mixed hyperlipidaemia	0.000	0.165	0.835
I25.8 Other forms of chronic ischaemic heart disease	0.000	0.172	0.828
E78.1 Pure hyperglyceridaemia	0.000	0.184	0.816
I25.4 Coronary artery aneurysm	0.000	0.184	0.816
E78.8 Other disorders of lipoprotein metabolism	0.000	0.229	0.771
I25.0 Atherosclerotic cardiovascular disease, so described	0.000	0.244	0.756
E78.6 Lipoprotein deficiency	0.000	0.287	0.713
E78.9 Disorder of lipoprotein metabolism, unspecified	0.000	0.294	0.706
I25.2 Old myocardial infarction	0.000	0.327	0.673
I25.9 Chronic ischaemic heart disease, unspecified	0.000	0.378	0.622
I25.6 Silent myocardial ischaemia	0.000	0.391	0.609
E78.3 Hyperchylomicronaemia	0.000	0.406	0.594
I25.5 Ischaemic cardiomyopathy	0.000	0.503	0.497
K76.0 Fatty (change of) liver, not elsewhere classified	0.000	0.518	0.482
Z95.1 Presence of aortocoronary bypass graft	0.000	0.773	0.227
K76 Other diseases of liver	0.000	0.843	0.157
K76.6 Portal hypertension	0.000	0.866	0.134
I21.1 Acute transmural myocardial infarction of inferior wall	0.000	0.879	0.121
K76.7 Hepatorenal syndrome	0.000	0.879	0.121
I20-I25 Ischaemic heart diseases	0.000	0.881	0.119
I21 Acute myocardial infarction	0.000	0.886	0.114
K76.5 Hepatic veno-occlusive disease	0.000	0.887	0.113
K76.4 Peliosis hepatis	0.000	0.887	0.113
K76.3 Infarction of liver	0.000	0.887	0.113
K76.2 Central haemorrhagic necrosis of liver	0.000	0.887	0.113
K76.9 Liver disease, unspecified	0.000	0.888	0.112
K76.1 Chronic passive congestion of liver	0.000	0.897	0.103
I21.0 Acute transmural myocardial infarction of anterior wall	0.000	0.906	0.094
I21.X Presumed acute myicardial infaction (unconfirmed)	0.000	0.918	0.082
I23 Certain current complications following acute myocardial infarction	0.000	0.931	0.069
I21.4 Acute subendocardial myocardial infarction	0.000	0.932	0.068
I21.3 Acute transmural myocardial infarction of unspecified site	0.000	0.948	0.051
I21.2 Acute transmural myocardial infarction of other sites	0.000	0.949	0.051
I23.6 Thrombosis of atrium, auricular appendage and ventricle as current complications following acute myocardial infarction	0.000	0.950	0.050
I23.5 Rupture of papillary muscle as current complication following acute myocardial infarction	0.000	0.950	0.050
I23.4 Rupture of chordae tendineae as current complication following acute myocardial infarction	0.000	0.950	0.050
I23.3 Rupture of cardiac wall without haemopericardium as current complication following acute myocardial infarction	0.000	0.950	0.050
I23.2 Ventricular septal defect as current complication following acute myocardial infarction	0.000	0.950	0.050
I23.1 Atrial septal defect as current complication following acute myocardial infarction	0.000	0.950	0.050
I23.0 Haemopericardium as current complication following acute myocardial infarction	0.000	0.950	0.050
I78.1 Naevus, nonneoplastic	0.000	0.951	0.049
I21.9 Acute myocardial infarction, unspecified	0.000	0.956	0.044
I22 Subsequent myocardial infarction	0.000	0.956	0.044
I78 Diseases of capillaries	0.000	0.959	0.041
I78.0 Hereditary haemorrhagic telangiectasia	0.000	0.961	0.039
I23.8 Other current complications following acute myocardial infarction	0.001	0.966	0.033
I22.9 Subsequent myocardial infarction of unspecified site	0.000	0.967	0.033
I78.9 Disease of capillaries, unspecified	0.000	0.969	0.031
I22.0 Subsequent myocardial infarction of anterior wall	0.000	0.971	0.029
I78.8 Other diseases of capillaries	0.000	0.974	0.026
I50.1 Left ventricular failure	0.000	0.975	0.025
K76.8 Other specified diseases of liver	0.000	0.975	0.025
I20 Angina pectoris	0.000	0.975	0.025
I73.9 Peripheral vascular disease, unspecified	0.000	0.976	0.024
I24 Other acute ischaemic heart diseases	0.000	0.978	0.022
I73 Other peripheral vascular diseases	0.000	0.979	0.021
I70-I79 Diseases of arteries, arterioles and capillaries	0.000	0.979	0.021
I71.4 Abdominal aortic aneurysm, without mention of rupture	0.000	0.980	0.020
I22.1 Subsequent myocardial infarction of inferior wall	0.000	0.980	0.020
I71 Aortic aneurysm and dissection	0.000	0.981	0.019
I73.8 Other specified peripheral vascular diseases	0.000	0.982	0.018
I22.8 Subsequent myocardial infarction of other sites	0.000	0.982	0.018
E10.3 With ophthalmic complications	0.018	0.982	0.000
B34.9 Viral infection, unspecified	0.000	0.983	0.017
I20.8 Other forms of angina pectoris	0.000	0.983	0.017
I71.6 Thoracoabdominal aortic aneurysm, without mention of rupture	0.000	0.984	0.015
I71.0 Dissection of aorta [any part]	0.000	0.985	0.015
I71.3 Abdominal aortic aneurysm, ruptured	0.000	0.985	0.015
I24.1 Dressler's syndrome	0.000	0.985	0.015
B34 Viral infection of unspecified site	0.000	0.986	0.014
I73.1 Thromboangiitis obliterans [Buerger]	0.000	0.986	0.014
I71.8 Aortic aneurysm of unspecified site, ruptured	0.000	0.986	0.014
I71.5 Thoracoabdominal aortic aneurysm, ruptured	0.000	0.986	0.014
I71.1 Thoracic aortic aneurysm, ruptured	0.000	0.986	0.014
I72 Other aneurysm	0.000	0.986	0.014
I24.0 Coronary thrombosis not resulting in myocardial infarction	0.000	0.986	0.014
E10 Insulin-dependent diabetes mellitus	0.013	0.987	0.000
B34.8 Other viral infections of unspecified site	0.000	0.988	0.012
E10.4 With neurological complications	0.012	0.988	0.000
B34.4 Papovirus infection, unspecified	0.000	0.988	0.012
I79 Disorders of arteries, arterioles and capillaries in diseases classified elsewhere	0.000	0.988	0.012
I50 Heart failure	0.000	0.988	0.012
I20.1 Angina pectoris with documented spasm	0.000	0.988	0.012
E10.5 With peripheral circulatory complications	0.012	0.988	0.000
I72.2 Aneurysm of renal artery	0.000	0.988	0.011
I72.1 Aneurysm of artery of upper extremity	0.000	0.988	0.011
I50.0 Congestive heart failure	0.000	0.989	0.011
I72.3 Aneurysm of iliac artery	0.000	0.989	0.011
I72.8 Aneurysm of other specified arteries	0.000	0.989	0.011
I74 Arterial embolism and thrombosis	0.000	0.989	0.011
K81.9 Cholecystitis, unspecified	0.011	0.989	0.000
I20.0 Unstable angina	0.000	0.989	0.011
I74.9 Embolism and thrombosis of unspecified artery	0.000	0.989	0.011
B34.3 Parvovirus infection, unspecified	0.000	0.990	0.010
B34.2 Coronavirus infection, unspecified	0.000	0.990	0.010
B34.0 Adenovirus infection, unspecified	0.000	0.990	0.010
I72.6 Aneurysm and dissection of vertebral artery	0.000	0.990	0.010
I72.5 Aneurysm and dissection of other precerebral arteries	0.000	0.990	0.010
B34.1 Enterovirus infection, unspecified	0.000	0.990	0.010
E10.6 With other specified complications	0.010	0.990	0.000
E10.1 With ketoacidosis	0.010	0.990	0.000
E10.0 With coma	0.010	0.990	0.000
E10.2 With renal complications	0.010	0.990	0.000
E10.7 With multiple complications	0.009	0.990	0.000
I74.5 Embolism and thrombosis of iliac artery	0.000	0.991	0.009
U89.8 Agent resistant to other single specified antibiotic	0.000	0.991	0.009
E10.8 With unspecified complications	0.009	0.991	0.000
I79.1 Aortitis in diseases classified elsewhere	0.000	0.991	0.009
I79.0 Aneurysm of aorta in diseases classified elsewhere	0.000	0.991	0.009
I20.9 Angina pectoris, unspecified	0.000	0.991	0.009
Z85.2 Personal history of malignant neoplasm of other respiratory and intrathoracic organs	0.009	0.991	0.000
I70 Atherosclerosis	0.000	0.991	0.008
I79.8 Other disorders of arteries, arterioles and capillaries in diseases classified elsewhere	0.000	0.991	0.008
I74.0 Embolism and thrombosis of abdominal aorta	0.000	0.992	0.008
I74.1 Embolism and thrombosis of other and unspecified parts of aorta	0.000	0.992	0.008
I24.9 Acute ischaemic heart disease, unspecified	0.000	0.992	0.008
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.008	0.992	0.000
B27.9 Infectious mononucleosis, unspecified	0.000	0.992	0.008
B27 Infectious mononucleosis	0.000	0.992	0.008
I74.4 Embolism and thrombosis of arteries of extremities, unspecified	0.000	0.992	0.007
B25-B34 Other viral diseases	0.000	0.992	0.008
R82.9 Other and unspecified abnormal finding in urine	0.000	0.993	0.007
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.007	0.993	0.000
I70.8 Atherosclerosis of other arteries	0.000	0.993	0.007
I72.9 Aneurysm of unspecified site	0.000	0.993	0.007
U89 Agent resistant to other and unspecified antibiotics	0.000	0.993	0.007
I72.4 Aneurysm of artery of lower extremity	0.000	0.993	0.007
I71.9 Aortic aneurysm of unspecified site, without mention of rupture	0.000	0.993	0.006
I79.2 Peripheral angiopathy in diseases classified elsewhere	0.000	0.994	0.006
T39.0 Salicylates	0.006	0.994	0.000
B27.0 Gammaherpesviral mononucleosis	0.000	0.994	0.006
I70.1 Atherosclerosis of renal artery	0.000	0.994	0.006
I35.2 Aortic (valve) stenosis with insufficiency	0.000	0.994	0.006
I74.2 Embolism and thrombosis of arteries of the upper extremities	0.000	0.994	0.006
I74.8 Embolism and thrombosis of other arteries	0.000	0.994	0.006
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.006	0.994	0.000
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.006	0.994	0.000
I72.0 Aneurysm of carotid artery	0.000	0.994	0.006
I70.80 Atherosclerosis of other arteries (without gangrene)	0.000	0.994	0.006
Chapter IX Diseases of the circulatory system	0.000	0.994	0.006
B27.8 Other infectious mononucleosis	0.000	0.994	0.006
B27.1 Cytomegaloviral mononucleosis	0.000	0.994	0.006
I70.9 Generalised and unspecified atherosclerosis	0.000	0.994	0.005
B30 Viral conjunctivitis	0.000	0.994	0.006
B26 Mumps	0.000	0.994	0.006
U89.9 Agent resistant to unspecified antibiotic	0.000	0.994	0.005
K70-K77 Diseases of liver	0.000	0.995	0.005
I70.81 Atherosclerosis of other arteries (with gangrene)	0.000	0.995	0.005
I70.0 Atherosclerosis of aorta	0.000	0.995	0.005
B33 Other viral diseases, not elsewhere classified	0.000	0.995	0.005
M46.99 Inflammatory spondylopathy, unspecified (Site unspecified)	0.000	0.995	0.005
I24.8 Other forms of acute ischaemic heart disease	0.000	0.995	0.005
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.005	0.995	0.000
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.005	0.995	0.000
I00-I02 Acute rheumatic fever	0.000	0.995	0.005
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.005	0.995	0.000
U82-U85 Resistance to antimicrobial and antineoplastic drugs	0.000	0.995	0.005
K81 Cholecystitis	0.005	0.995	0.000
T50.9 Other and unspecified drugs, medicaments and biological substances	0.005	0.995	0.000
I70.11 Atherosclerosis of renal artery (with gangrene)	0.000	0.995	0.004
I71.2 Thoracic aortic aneurysm, without mention of rupture	0.000	0.995	0.004
S82.10 Fracture of upper end of tibia (closed)	0.005	0.995	0.000
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.004	0.995	0.000
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.004	0.995	0.000
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.004	0.995	0.000
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.004	0.995	0.000
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.004	0.995	0.000
T44.1 Other parasympathomimetics [cholinergics]	0.004	0.995	0.000
T44.0 Anticholinesterase agents	0.004	0.995	0.000
T39.4 Antirheumatics, not elsewhere classified	0.004	0.995	0.000
T39.2 Pyrazolone derivatives	0.004	0.995	0.000
T36-T50 Poisoning by drugs, medicaments and biological substances	0.005	0.995	0.000
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.004	0.996	0.000
I70.91 Generalized and unspecified atherosclerosis (with gangrene)	0.000	0.996	0.004
K71 Toxic liver disease	0.000	0.996	0.004
B26.9 Mumps without complication	0.000	0.996	0.004
B26.8 Mumps with other complications	0.000	0.996	0.004
B26.3 Mumps pancreatitis	0.000	0.996	0.004
B26.2 Mumps encephalitis	0.000	0.996	0.004
B26.1 Mumps meningitis	0.000	0.996	0.004
B26.0 Mumps orchitis	0.000	0.996	0.004
B30.9 Viral conjunctivitis, unspecified	0.000	0.996	0.004
B30.8 Other viral conjunctivitis	0.000	0.996	0.004
B30.3 Acute epidemic haemorrhagic conjunctivitis (enteroviral)	0.000	0.996	0.004
B30.2 Viral pharyngoconjunctivitis	0.000	0.996	0.004
B30.1 Conjunctivitis due to adenovirus	0.000	0.996	0.004
B30.0 Keratoconjunctivitis due to adenovirus	0.000	0.996	0.004
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.004	0.996	0.000
T37.8 Other specified systemic anti-infectives and antiparasitics	0.004	0.996	0.000
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.004	0.996	0.000
I70.10 Atherosclerosis of renal artery (without gangrene)	0.000	0.996	0.004
K81.0 Acute cholecystitis	0.004	0.996	0.000
K77 Liver disorders in diseases classified elsewhere	0.000	0.996	0.004
B25 Cytomegaloviral disease	0.000	0.996	0.004
I00 Rheumatic fever without mention of heart involvement	0.000	0.996	0.004
T50.8 Diagnostic agents	0.004	0.996	0.000
I70.01 Atherosclerosis of aorta (with gangrene)	0.000	0.996	0.004
I70.2 Atherosclerosis of arteries of the extremities	0.000	0.996	0.004
R82 Other abnormal findings in urine	0.000	0.996	0.004
I73.0 Raynaud's syndrome	0.000	0.996	0.004
K71.6 Toxic liver disease with hepatitis, not elsewhere classified	0.000	0.996	0.004
S82.70 Multiple fractures of lower leg (closed)	0.004	0.996	0.000
B33.4 Hantavirus (cardio-)pulmonary syndrome [HPS] [HCPS]	0.000	0.996	0.004
B33.3 Retrovirus infections, not elsewhere classified	0.000	0.996	0.004
B33.1 Ross River disease	0.000	0.996	0.004
B33.0 Epidemic myalgia	0.000	0.996	0.004
T50.4 Drugs affecting uric acid metabolism	0.004	0.996	0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.004	0.996	0.000
T50.1 Loop [high-ceiling] diuretics	0.004	0.996	0.000
K73 Chronic hepatitis, not elsewhere classified	0.000	0.996	0.004
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.004	0.996	0.000
T50.7 Analeptics and opioid receptor antagonists	0.004	0.996	0.000
T50.5 Appetite depressants	0.004	0.996	0.000
T50.3 Electrolytic, caloric and water-balance agents	0.004	0.996	0.000
T50.0 Mineralocorticoids and their antagonists	0.004	0.996	0.000
I02 Rheumatic chorea	0.000	0.996	0.003
I01 Rheumatic fever with heart involvement	0.000	0.996	0.003
S82.1 Fracture of upper end of tibia	0.004	0.996	0.000
U84 Resistance to other antimicrobial drugs	0.000	0.996	0.003
U83 Resistance to other antibiotics	0.000	0.996	0.003
U82 Resistance to betalactam antibiotics	0.000	0.996	0.003
U85 Resistance to antineoplastic drugs	0.000	0.996	0.003
I70.90 Generalized and unspecified atherosclerosis (without gangrene)	0.001	0.996	0.003
B33.8 Other specified viral diseases	0.000	0.996	0.003
B33.2 Viral carditis	0.000	0.996	0.003
T50.6 Antidotes and chelating agents, not elsewhere classified	0.003	0.996	0.000
U88 Agent resistant to multiple antibiotics	0.000	0.996	0.004
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.004	0.996	0.000
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.004	0.996	0.000
K71.1 Toxic liver disease with hepatic necrosis	0.000	0.996	0.003
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.003	0.996	0.000
T41 Poisoning by anaesthetics and therapeutic gases	0.003	0.996	0.000
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.003	0.997	0.000
H93.1 Tinnitus	0.000	0.997	0.003
K71.8 Toxic liver disease with other disorders of liver	0.000	0.997	0.003
K71.7 Toxic liver disease with fibrosis and cirrhosis of liver	0.000	0.997	0.003
K71.5 Toxic liver disease with chronic active hepatitis	0.000	0.997	0.003
K71.4 Toxic liver disease with chronic lobular hepatitis	0.000	0.997	0.003
K71.3 Toxic liver disease with chronic persistent hepatitis	0.000	0.997	0.003
K71.2 Toxic liver disease with acute hepatitis	0.000	0.997	0.003
I98.2 Oesophageal varices in diseases classified elsewhere	0.000	0.997	0.003
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.003	0.997	0.000
T37.5 Antiviral drugs	0.003	0.997	0.000
T37.4 Anthelminthics	0.003	0.997	0.000
T37.3 Other antiprotozoal drugs	0.003	0.997	0.000
T37.2 Antimalarials and drugs acting on other blood protozoa	0.003	0.997	0.000
T37.1 Antimycobacterial drugs	0.003	0.997	0.000
T37.0 Sulphonamides	0.003	0.997	0.000
S82.11 Fracture of upper end of tibia (open)	0.003	0.997	0.000
U80.8 Agent resistant to other penicillin-related antibiotic	0.000	0.997	0.003
R82.5 Elevated urine levels of drugs, medicaments and biological substances	0.000	0.997	0.003
I50.9 Heart failure, unspecified	0.000	0.997	0.003
K77.8 Liver disorders in other diseases classified elsewhere	0.000	0.997	0.003
K77.0 Liver disorders in infectious and parasitic diseases classified elsewhere	0.000	0.997	0.003
K71.0 Toxic liver disease with cholestasis	0.000	0.997	0.003
L43.9 Lichen planus, unspecified	0.003	0.997	0.000
I98 Other disorders of circulatory system in diseases classified elsewhere	0.000	0.997	0.003
T43.3 Phenothiazine antipsychotics and neuroleptics	0.003	0.997	0.000
U00-U49 Provisional assignment of new diseases of uncertain etiology or emergency use	0.000	0.997	0.003
B25.2 Cytomegaloviral pancreatitis	0.000	0.997	0.003
B25.1 Cytomegaloviral hepatitis	0.000	0.997	0.003
T43.0 Tricyclic and tetracyclic antidepressants	0.003	0.997	0.000
Chapter XXII Codes for special purposes	0.000	0.997	0.003
C32.0 Glottis	0.003	0.997	0.000
K81.1 Chronic cholecystitis	0.003	0.997	0.000
R82.6 Abnormal urine levels of substances chiefly nonmedicinal as to source	0.000	0.997	0.003
R82.3 Haemoglobinuria	0.000	0.997	0.003
R82.2 Biliuria	0.000	0.997	0.003
R82.0 Chyluria	0.000	0.997	0.003
T43.2 Other and unspecified antidepressants	0.003	0.997	0.000
K73.8 Other chronic hepatitis, not elsewhere classified	0.000	0.997	0.003
R82.1 Myoglobinuria	0.000	0.997	0.003
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.003	0.997	0.000
K71.9 Toxic liver disease, unspecified	0.000	0.997	0.003
K73.9 Chronic hepatitis, unspecified	0.000	0.997	0.003
S82.7 Multiple fractures of lower leg	0.003	0.997	0.000
T38.9 Other and unspecified hormone antagonists	0.003	0.997	0.000
T38.8 Other and unspecified hormones and their synthetic substitutes	0.003	0.997	0.000
T38.7 Androgens and anabolic congeners	0.003	0.997	0.000
T38.5 Other oestrogens and progestogens	0.003	0.997	0.000
T38.4 Oral contraceptives	0.003	0.997	0.000
T38.2 Antithyroid drugs	0.003	0.997	0.000
T38.1 Thyroid hormones and substitutes	0.003	0.997	0.000
U80 Agent resistant to penicillin and related antibiotics	0.000	0.997	0.003
C53.0 Endocervix	0.000	0.997	0.003
K73.1 Chronic lobular hepatitis, not elsewhere classified	0.000	0.997	0.003
K73.0 Chronic persistent hepatitis, not elsewhere classified	0.000	0.997	0.003
K81.8 Other cholecystitis	0.003	0.997	0.000
T47.6 Antidiarrhoeal drugs	0.003	0.997	0.000
Z89.5 Acquired absence of leg at or below knee	0.003	0.997	0.000
I95-I99 Other and unspecified disorders of the circulatory system	0.000	0.997	0.003
T43.6 Psychostimulants with abuse potential	0.003	0.997	0.000
R82.4 Acetonuria	0.000	0.997	0.003
T38.0 Glucocorticoids and synthetic analogues	0.003	0.997	0.000
I77 Other disorders of arteries and arterioles	0.000	0.997	0.003
I01.9 Acute rheumatic heart disease, unspecified	0.000	0.997	0.003
I01.8 Other acute rheumatic heart disease	0.000	0.997	0.003
I01.2 Acute rheumatic myocarditis	0.000	0.997	0.003
I01.1 Acute rheumatic endocarditis	0.000	0.997	0.003
I01.0 Acute rheumatic pericarditis	0.000	0.997	0.003
I02.9 Rheumatic chorea without heart involvement	0.000	0.997	0.003
I02.0 Rheumatic chorea with heart involvement	0.000	0.997	0.003
R82.7 Abnormal findings on microbiological examination of urine	0.000	0.997	0.003
U82.9 Resistance to betalactam antibiotics, unspecified	0.000	0.997	0.003
U82.8 Resistance to other betalactam antibiotics	0.000	0.997	0.003
U82.2 Extended spectrum betalactamase (ESBL) resistance	0.000	0.997	0.003
U82.1 Resistance to methicillin	0.000	0.997	0.003
U82.0 Resistance to penicillin	0.000	0.997	0.003
U83.9 Resistance to unspecified antibiotic	0.000	0.997	0.003
U83.8 Resistance to other single specified antibiotic	0.000	0.997	0.003
U83.7 Resistance to multiple antibiotics	0.000	0.997	0.003
U83.2 Resistance to quinolones	0.000	0.997	0.003
U83.1 Resistance to other vancomycin related antibiotics	0.000	0.997	0.003
U83.0 Resistance to vancomycin	0.000	0.997	0.003
U84.9 Resistance to unspecified antimicrobial drugs	0.000	0.997	0.003
U84.8 Resistance to other specified antimicrobial drug	0.000	0.997	0.003
U84.7 Resistance to multiple antimicrobial drugs	0.000	0.997	0.003
U84.3 Resistance to tuberculostatic drug(s)	0.000	0.997	0.003
U84.2 Resistance to antiviral drug(s)	0.000	0.997	0.003
U84.1 Resistance to antifungal drug(s)	0.000	0.997	0.003
U84.0 Resistance to antiparasitic drug(s)	0.000	0.997	0.003
T36 Poisoning by systemic antibiotics	0.003	0.997	0.000
U81 Agent resistant to vancomycin and related antibiotics	0.000	0.997	0.003
B25.0 Cytomegaloviral pneumonitis	0.000	0.997	0.003
B25.9 Cytomegaloviral disease, unspecified	0.000	0.997	0.003
C32.9 Larynx, unspecified	0.003	0.997	0.000
I98.3 Oesophageal varices with bleeding in diseases classified elsewhere	0.000	0.997	0.003
T47.2 Stimulant laxatives	0.003	0.997	0.000
W50.9 Unspecified place	0.003	0.997	0.000
T43.8 Other psychotropic drugs, not elsewhere classified	0.003	0.997	0.000
T41.5 Therapeutic gases	0.003	0.997	0.000
T41.4 Anaesthetic, unspecified	0.003	0.997	0.000
T41.3 Local anaesthetics	0.003	0.997	0.000
T41.2 Other and unspecified general anaesthetics	0.003	0.997	0.000
T41.1 Intravenous anaesthetics	0.003	0.997	0.000
T41.0 Inhaled anaesthetics	0.003	0.997	0.000
T49.9 Topical agent, unspecified	0.003	0.997	0.000
T49.8 Other topical agents	0.003	0.997	0.000
T49.7 Dental drugs, topically applied	0.003	0.997	0.000
T49.6 Otorhinolaryngological drugs and preparations	0.003	0.997	0.000
T49.5 Ophthalmological drugs and preparations	0.003	0.997	0.000
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.003	0.997	0.000
T49.3 Emollients, demulcents and protectants	0.003	0.997	0.000
T49.2 Local astringents and local detergents	0.003	0.997	0.000
T49.1 Antipruritics	0.003	0.997	0.000
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.003	0.997	0.000
Z89.9 Acquired absence of limb, unspecified	0.003	0.997	0.000
K92.2 Gastro-intestinal haemorrhage, unspecified	0.003	0.997	0.000
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.003	0.997	0.000
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.003	0.997	0.000
T47.8 Other agents primarily affecting the gastro-intestinal system	0.003	0.997	0.000
T47.7 Emetics	0.003	0.997	0.000
T47.5 Digestants	0.003	0.997	0.000
T47.3 Saline and osmotic laxatives	0.003	0.997	0.000
K72 Hepatic failure, not elsewhere classified	0.000	0.997	0.003
T43.9 Psychotropic drug, unspecified	0.003	0.997	0.000
U51.0 Not Previously admitted to a psyciatric hospital	0.000	0.997	0.003
U81.0 Vancomycin resistant agent	0.000	0.997	0.003
H26.2 Complicated cataract	0.000	0.997	0.003
U51 Admission status on psychiatric patients	0.000	0.997	0.003
B25.8 Other cytomegaloviral diseases	0.000	0.997	0.002
L43.8 Other lichen planus	0.003	0.997	0.000
T47.1 Other antacids and anti-gastric-secretion drugs	0.003	0.997	0.000
L43 Lichen planus	0.003	0.997	0.000
I98.8 Other specified disorders of circulatory system in diseases classified elsewhere	0.000	0.997	0.002
I98.1 Cardiovascular disorders in other infectious and parasitic diseases classified elsewhere	0.000	0.997	0.002
I98.0 Cardiovascular syphilis	0.000	0.997	0.002
I70.00 Atherosclerosis of aorta (without gangrene)	0.000	0.997	0.002
U50 Level of care administered to neonates	0.000	0.997	0.002
U07 Emergency use of U07	0.000	0.997	0.002
U06 Emergency use of U06	0.000	0.997	0.002
U04 Severe acute respiratory syndrome [SARS]	0.000	0.997	0.002
U52 First in a series of a regular day/night admissions	0.000	0.997	0.002
O72.0 Third-stage haemorrhage	0.000	0.997	0.003
T47.4 Other laxatives	0.002	0.997	0.000
W50 Hit, struck, kicked, twisted, bitten or scratched by another person	0.003	0.997	0.000
T47.0 Histamine H(2)-receptor antagonists	0.002	0.997	0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.002	0.997	0.000
Z89 Acquired absence of limb	0.003	0.997	0.000
E28.2 Polycystic ovarian syndrome	0.000	0.997	0.003
F52.2 Failure of genital response	0.003	0.997	0.000
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.002	0.997	0.000
C44.5 Skin of trunk	0.003	0.997	0.000
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.002	0.998	0.000
T48.4 Expectorants	0.002	0.998	0.000
T48.3 Antitussives	0.002	0.998	0.000
T48.2 Other and unspecified agents primarily acting on muscles	0.002	0.998	0.000
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.002	0.998	0.000
T48.0 Oxytocic drugs	0.002	0.998	0.000
S82.71 Multiple fractures of lower leg (open)	0.002	0.998	0.000
R82.8 Abnormal findings on cytological and histological examination of urine	0.000	0.998	0.002
Q27.8 Other specified congenital malformations of peripheral vascular system	0.002	0.998	0.000
T36.4 Tetracyclines	0.002	0.998	0.000
Z89.0 Acquired absence of finger(s) [including thumb], unilateral	0.002	0.998	0.000
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.002	0.998	0.000
Z95 Presence of cardiac and vascular implants and grafts	0.000	0.998	0.002
S82.90 Fracture of lower leg, part unspecified (closed)	0.002	0.998	0.000
C32 Malignant neoplasm of larynx	0.002	0.998	0.000
E22.0 Acromegaly and pituitary gigantism	0.002	0.998	0.000
I77.5 Necrosis of artery	0.000	0.998	0.002
I77.4 Coeliac artery compression syndrome	0.000	0.998	0.002
N97.9 Female infertility, unspecified	0.000	0.998	0.002
Q23.1 Congenital insufficiency of aortic valve	0.002	0.998	0.000
S82.9 Fracture of lower leg, part unspecified	0.002	0.998	0.000
T36.9 Systemic antibiotic, unspecified	0.002	0.998	0.000
T36.8 Other systemic antibiotics	0.002	0.998	0.000
T36.7 Antifungal antibiotics, systemically used	0.002	0.998	0.000
T36.6 Rifamycins	0.002	0.998	0.000
T36.5 Aminoglycosides	0.002	0.998	0.000
T36.2 Chloramphenicol group	0.002	0.998	0.000
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.002	0.998	0.000
S82 Fracture of lower leg, including ankle	0.002	0.998	0.000
Z89.6 Acquired absence of leg above knee	0.002	0.998	0.000
K73.2 Chronic active hepatitis, not elsewhere classified	0.000	0.998	0.002
T48.5 Anti-common-cold drugs	0.002	0.998	0.000
W50.0 Home	0.002	0.998	0.000
I70.21 Atherosclerosis of arteries of extremities (with gangrene)	0.001	0.998	0.002
Q23 Congenital malformations of aortic and mitral valves	0.002	0.998	0.000
S02.40 Fracture of malar and maxillary bones (closed)	0.002	0.998	0.000
W50.8 Other specified place	0.002	0.998	0.000
U81.8 Agent resistant to other vancomycin-related antibiotic	0.000	0.998	0.002
K74 Fibrosis and cirrhosis of liver	0.000	0.998	0.002
W51.9 Unspecified place	0.002	0.998	0.000
Z89.8 Acquired absence of upper and lower limbs [any level]	0.002	0.998	0.000
W51 Striking against or bumped into by another person	0.002	0.998	0.000
M23.39 Other meniscus derangements (Unspecified ligament or Unspecified meniscus)	0.002	0.998	0.000
Q23.3 Congenital mitral insufficiency	0.002	0.998	0.000
S82.5 Fracture of medial malleolus	0.002	0.998	0.000
T43.4 Butyrophenone and thioxanthene neuroleptics	0.002	0.998	0.000
T48.6 Antiasthmatics, not elsewhere classified	0.002	0.998	0.000
U51.2 Previously admitted to a psychiatric hospital of another provider	0.000	0.998	0.002
A41.0 Septicaemia due to Staphylococcus aureus	0.000	0.998	0.002
W51.5 Trade and service area	0.002	0.998	0.000
R80-R82 Abnormal findings on examination of urine, without diagnosis	0.000	0.998	0.002
L43.0 Hypertrophic lichen planus	0.002	0.998	0.000
S82.51 Fracture of medial malleolus (open)	0.002	0.998	0.000
K72.0 Acute and subacute hepatic failure	0.000	0.998	0.002
L43.3 Subacute (active) lichen planus	0.002	0.998	0.000
L43.2 Lichenoid drug reaction	0.002	0.998	0.000
L43.1 Bullous lichen planus	0.002	0.998	0.000
D61.9 Aplastic anaemia, unspecified	0.000	0.998	0.002
K75.3 Granulomatous hepatitis, not elsewhere classified	0.000	0.998	0.002
I77.8 Other specified disorders of arteries and arterioles	0.000	0.998	0.002
I77.3 Arterial fibromuscular dysplasia	0.000	0.998	0.002
T40.5 Cocaine	0.002	0.998	0.000
U04.9 Severe acute respiratory syndrome [SARS], unspecified	0.000	0.998	0.002
U06.9 Emergency use of U06.9	0.000	0.998	0.002
U06.8 Emergency use of U06.8	0.000	0.998	0.002
U06.7 Emergency use of U06.7	0.000	0.998	0.002
U06.6 Emergency use of U06.6	0.000	0.998	0.002
U06.5 Emergency use of U06.5	0.000	0.998	0.002
U06.4 Emergency use of U06.4	0.000	0.998	0.002
U06.3 Emergency use of U06.3	0.000	0.998	0.002
U06.2 Emergency use of U06.2	0.000	0.998	0.002
U06.1 Emergency use of U06.1	0.000	0.998	0.002
U06.0 Emergency use of U06.0	0.000	0.998	0.002
U07.9 Emergency use of U07.9	0.000	0.998	0.002
U07.8 Emergency use of U07.8	0.000	0.998	0.002
U07.7 Emergency use of U07.7	0.000	0.998	0.002
U07.6 Emergency use of U07.6	0.000	0.998	0.002
U07.5 Emergency use of U07.5	0.000	0.998	0.002
U07.4 Emergency use of U07.4	0.000	0.998	0.002
U07.3 Emergency use of U07.3	0.000	0.998	0.002
U07.2 Emergency use of U07.2	0.000	0.998	0.002
U07.1 Emergency use of U07.1	0.000	0.998	0.002
U07.0 Emergency use of U07.0	0.000	0.998	0.002
U50.9 Inquest Adjourned Death	0.000	0.998	0.002
U50.3 Level of care administered to neonates (Maximal Intensive Care)	0.000	0.998	0.002
U50.2 Level of care administered to neonates (High Dependancy Intensive Care)	0.000	0.998	0.002
U50.1 Level of care administered to neonates (Special Care)	0.000	0.998	0.002
U50.0 Level of care administered to neonates (Normal Care)	0.000	0.998	0.002
Q27 Other congenital malformations of peripheral vascular system	0.002	0.998	0.000
Q23.0 Congenital stenosis of aortic valve	0.002	0.998	0.000
T36.3 Macrolides	0.002	0.998	0.000
Y65.8 Other specified misadventures during surgical and medical care	0.002	0.998	0.000
Z03.9 Observation for suspected disease or condition, unspecified	0.002	0.998	0.000
Z89.7 Acquired absence of both lower limbs [any level, except toes alone]	0.002	0.998	0.000
S82.4 Fracture of fibula alone	0.002	0.998	0.000
W50.3 Sports and athletics area	0.002	0.998	0.000
W50.7 Farm	0.002	0.998	0.000
W50.6 Industrial and construction area	0.002	0.998	0.000
W50.5 Trade and service area	0.002	0.998	0.000
W50.1 Residential institution	0.002	0.998	0.000
I70.20 Atherosclerosis of arteries of extremities (without gangrene)	0.000	0.998	0.002
I74.3 Embolism and thrombosis of arteries of the lower extremities	0.000	0.998	0.002
I77.2 Rupture of artery	0.000	0.998	0.002
O61.0 Failed medical induction of labour	0.002	0.998	0.000
T45.9 Primarily systemic and haematological agent, unspecified	0.002	0.998	0.000
T45.8 Other primarily systemic and haematological agents	0.002	0.998	0.000
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.002	0.998	0.000
T45.6 Fibrinolysis-affecting drugs	0.002	0.998	0.000
T45.4 Iron and its compounds	0.002	0.998	0.000
T45.3 Enzymes, not elsewhere classified	0.002	0.998	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations